Lifeboat Foundation

Israeli scientists have made yet another cancer treatment breakthrough, this time using nanosized polymers. Researchers from Ben Gurion University say they developed a way to selectively deliver chemotherapeutic drugs to blood vessels that feed tumors and metastases.

The polymer eliminates colorectal cancer liver metastases and prolongs mice survival, after a single dose-therapy, they said. The findings were published in Nano Today, a leading journal in the field of nanotechnology.

A nanosized polymer is a polymer that has been engineered to have dimensions in the nanometer range. By comparison, a human hair is about 80,000–100,000 nanometers wide. These tiny particles offer unique properties that make them desirable for a wide range of applications.

There are trillions of microorganisms living in our gastrointestinal tract. So why doesn’t the immune system launch a massive response against all of those foreign microbes? Scientists have now provided new details about the process. The findings have been reported in Nature.

The gut microbiome has to maintain a careful balance, and promote the growth of healthy and beneficial organisms while tamping down the growth of potential pathogens. While scientists have not defined exactly what a healthy microbiome is made of, and it may differ from one person to another, we do know that when the balance in the microbial community of the gut is disrupted, health problems can arise.

Scientists studying learning in mice have inadvertently encountered ‘zombie neurons’ in the brain – not flesh-eating, virus-spreading monsters, but cells that stop interacting normally even though they’re functionally alive. What’s more, they shed new light on learning processes in the brain.

A team from Portugal discovered the cells as part of an investigation into how a part of the brain called the cerebellum learns from the environment around us.

The cerebellum processes sensory information related to motor movements. It helps us walk down a crowded street, or pick up a drink without spilling it, and it’s also important for learning: so if we bump into something, we know how to refine our movement to avoid it next time. Exactly how that learning happens was the subject of this new study.

🦠🔬🩹

Study explores how wound microbiota affect skin repair and infection risk by altering host immune responses, underscoring the complexity of microbial interactions in wound healing.

Using only DNA and glass, researchers made a material four times stronger and five times lighter than steel. It was inspired by Iron Man.

Your immune system should ideally recognize and attack infectious invaders and cancerous cells. But the system requires safety mechanisms, or brakes, to keep it from damaging healthy cells. To do this, T cells—the immune system’s most powerful attackers—rely on immune “checkpoints” to turn immune activation down when they receive the right signal. While these interactions have been well studied, a research team supported in part by NIH has made an unexpected discovery into how a key immune checkpoint works, with potentially important implications for therapies designed to boost or dampen immune activity to treat cancer and autoimmune diseases.¹

The checkpoint in question is a protein called programmed cell death-1 (PD-1). Here’s how it works: PD-1 is a receptor on the surface of T cells, where it latches onto certain proteins, known as PD-L1 and PD-L2, on the surface of other cells in the body. When this interaction occurs, a signal is sent to the T cells that stops them from attacking these other cells.

Cancer cells often take advantage of this braking system, producing copious amounts of PD-L1 on their surface, allowing them to hide from T cells. An effective class of immunotherapy drugs used to treat many cancers works by blocking the interaction between PD-1 and PD-L1, to effectively release the brakes on the immune system to allow the T cells to unleash an assault on cancer cells. Researchers have also developed potential treatments for autoimmune diseases that take the opposite tact: stimulating PD-1 interaction to keep T cells inactive. These PD-1 “agonists” have shown promise in clinical trials as treatments for certain autoimmune diseases.

Researchers from Nottingham Trent University (NTU) have developed realistic 3D printed heart and lung models that can bleed, beat and breathe like their real counterparts.

Designed for organ transplant training, the lifelike models reportedly reflect the tactile qualities of a human heart and can be produced with various tissue hardness levels. Using the models, medical professionals can plan surgeries and safely research and teach transplant procedures, without the risk of complications.

The project, which was led by research fellow Richard Arm, leveraged 3D scans of both healthy and diseased human hearts to 3D print the models to a high level of accuracy.

Scientists develop a human neuron model that efficiently simulates tau protein spread in Alzheimer’s, hinting at new therapeutic targets.

It reduces stress, boosts the immune system, and relieves pain. Touch is even crucial to our survival. Babies can die if they don’t get it. Additionally, the lack of it in a child’s‘life can stunt their growth in various ways.

Thus, scientists at Saarland University developed the smart textile with therapeutic and medicinal value in mind.

They claim that with this technology, seriously ill children in hospital isolation wards gain the chance to feel their parents’ closeness.